Coordination of Processing and Transport of mRNA
mRNA 加工和运输的协调
基本信息
- 批准号:6887312
- 负责人:
- 金额:$ 42.84万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-05-01 至 2006-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The long-term objective of the proposed research is to understand the mechanism by which mRNAs are exported out of the nucleus. The process of mRNA export includes: proper processing, packaging into protein-RNA complexes, targeting to and movement through the nuclear pore complex and release into the cytoplasm for translation. A transport machinery distinct from that for protein export has been proposed for mRNAs. As with protein import and export, mRNA export can also be regulated by, for example, growth conditions and viral infection. The Specific Aims are to determine how: 1) mRNAs are co- transcriptionally recruited for export; 2) mRNAs are recognized in the nucleus by certain RNA binding proteins; 3) mRNAs are selectively exported under conditions of stress; and 4) protein methylation of RNA binding proteins at arginine affects their activity. Defects in mRNA metabolism that can affect transport are associated with a number of diseases thus contributing to the health-relatedness of the project. For example, splicing and 3' end formation are associated with a number of diseases including metastatic cancers, muscular dystrophy and amyotrophic lateral sclerosis. In addition, some viruses exploit the endogenous nuclear transport machinery in order to propagate - in some cases by inhibiting export of host in favor of viral messages. Methylation of RNA and DNA binding proteins at arginine has recently emerged as important for many levels of regulation including viral RNA export, response of cells to interferon and the action of certain RNA binding proteins in motor neuron degeneration in spinal muscular atrophy. Lastly, arginine-methylated proteins such as hnRNPs and myelin basic protein are prominent in autoimmune diseases such as systemic lupus erythematosus and multiple sclerosis. It may be that modified arginine elicits special recognition properties that lead to exacerbation of autoimmune diseases.
拟议研究的长期目标是了解将mRNA从细胞核中导出的机制。 mRNA输出的过程包括:适当的加工,包装到蛋白质-RNA复合物中,靶向和通过核孔复合物运动并释放到细胞质中进行翻译。 已经提出了一种与蛋白质导出不同的运输机制。 与蛋白质进口和出口一样,mRNA输出也可以受到例如生长条件和病毒感染的调节。具体目的是确定:1)MRNA是在转录上招募出口的; 2)在细胞核中通过某些RNA结合蛋白识别mRNA; 3)在压力条件下,mRNA被选择性地出口; 4)精氨酸的RNA结合蛋白的蛋白甲基化会影响其活性。可能影响运输的mRNA代谢缺陷与多种疾病有关,从而导致该项目的健康相关性。 例如,剪接和3'端形成与多种疾病有关,包括转移性癌症,肌肉营养不良和肌萎缩性侧面硬化症。 此外,某些病毒利用内源性核运输机制来传播 - 在某些情况下,通过抑制宿主出口而有利于病毒信息。 对于许多水平的调节,包括病毒RNA输出,细胞对干扰素的反应以及在脊柱肌肉萎缩中运动神经元变性中某些RNA结合蛋白的作用,RNA和DNA结合蛋白在精氨酸上的甲基化最近出现了。 最后,精氨酸 - 甲基化蛋白(例如HNRNP和髓磷脂碱性蛋白)在自身免疫性疾病中很明显,例如全身性红斑狼疮和多发性硬化症。修饰的精氨酸可能引起特殊识别特性,从而导致自身免疫性疾病加剧。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
Pamela A Silver的其他基金
Harvard Systems Biology Graduate Program
哈佛系统生物学研究生项目
- 批准号:82931258293125
- 财政年份:2010
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
Harvard Systems Biology Graduate Program
哈佛系统生物学研究生项目
- 批准号:86882648688264
- 财政年份:2010
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
Connecting the Genome to the Cytoplasm
连接基因组与细胞质
- 批准号:80467258046725
- 财政年份:2010
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
Harvard Systems Biology Graduate Program
哈佛系统生物学研究生项目
- 批准号:84884458488445
- 财政年份:2010
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
Harvard Systems Biology Graduate Program
哈佛系统生物学研究生项目
- 批准号:80801818080181
- 财政年份:2010
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
Harvard Systems Biology Graduate Program
哈佛系统生物学研究生项目
- 批准号:77641657764165
- 财政年份:2010
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
COORDINATION OF PROCESSING AND TRANSPORT OF MRNAS
MRNAS 处理和运输的协调
- 批准号:63868806386880
- 财政年份:1998
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
Connecting the Genome to the Cytoplasm
连接基因组与细胞质
- 批准号:72285677228567
- 财政年份:1998
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
Coordination of Processing and Transport of mRNA
mRNA 加工和运输的协调
- 批准号:67626816762681
- 财政年份:1998
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
COORDINATION OF PROCESSING AND TRANSPORT OF MRNAS
MRNAS 处理和运输的协调
- 批准号:25998112599811
- 财政年份:1998
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
相似国自然基金
靶向大豆疫霉几丁质合成酶的新型抑制剂虚拟筛选、合成与活性研究
- 批准号:32302399
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
氰醇酯类肠道病毒71型3C蛋白酶抑制剂的设计、合成及活性研究
- 批准号:82304314
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
结构生物学导向的非核苷类HIV-1逆转录酶抑制剂设计、合成与生物活性研究
- 批准号:22377097
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
新型二芳基嘧啶类逆转录酶抑制剂的设计、合成及抗HIV病毒活性研究
- 批准号:82304297
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活性口袋区水分子簇和构象灵活性调控丝氨酸蛋白酶催化活性的机制及靶向酶抑制剂的研究
- 批准号:32370990
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Developing Antivirals Targeting Proteases and Polymerases of Coronaviruses, Picornaviruses and Bunyavirales
开发针对冠状病毒、小核糖核酸病毒和布尼亚病毒的蛋白酶和聚合酶的抗病毒药物
- 批准号:1051262810512628
- 财政年份:2022
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
Defining the mechanisms of kinetoplast DNA assembly by trypanosomal topoisomerase II for therapeutic target development
定义锥虫拓扑异构酶 II 的动质体 DNA 组装机制,用于治疗靶点开发
- 批准号:1038684910386849
- 财政年份:2021
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
Novel Target, New Therapy: Anti- Renalase Antibody for Tumors Resistant to PD-1Inhibitors
新靶点、新疗法:抗肾酶抗体治疗对 PD-1 抑制剂耐药的肿瘤
- 批准号:1032342110323421
- 财政年份:2018
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
Novel Target, New Therapy: Anti- Renalase Antibody for Tumors Resistant to PD-1Inhibitors
新靶点、新疗法:抗肾酶抗体治疗对 PD-1 抑制剂耐药的肿瘤
- 批准号:1046893910468939
- 财政年份:2018
- 资助金额:$ 42.84万$ 42.84万
- 项目类别:
CATHEPSIN L INHIBITORS AS PAN-CORONAVIRUS THERAPEUTICS
组织蛋白酶 L 抑制剂作为泛冠状病毒治疗药物
- 批准号:90144979014497
- 财政年份:2015
- 资助金额:$ 42.84万$ 42.84万
- 项目类别: